Who has invested in Faze Medicines?

Third Rock Ventures, Novartis Venture Fund, Eli Lilly are named among the investors backing Faze Medicines.

Faze Medicines Funding: $81M Raised, Series A (2020)

Faze Medicines funding overview

Faze Medicines is based in Cambridge. Faze Medicines has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2020. The round record for Faze Medicines runs through 2020; nothing later has been disclosed. Investors on record include Third Rock Ventures, Novartis Venture Fund, Eli Lilly. 3 distinct backers are named across the disclosed rounds.

Faze Medicines at a glance

Total raised: $81M
Latest round: Series A
Latest round date: December 2020
Headquarters: Cambridge
Notable investors: Third Rock Ventures, Novartis Venture Fund, Eli Lilly

Frequently asked about Faze Medicines funding

How much has Faze Medicines raised?: Faze Medicines has raised $81M in total disclosed funding across the rounds on record.
Who has invested in Faze Medicines?: Third Rock Ventures, Novartis Venture Fund, Eli Lilly are named among the investors backing Faze Medicines.
What was the latest Faze Medicines funding round?: The most recent disclosed round is a Series A, announced in December 2020.
Where is Faze Medicines based?: Faze Medicines is based in Cambridge.
When did Faze Medicines last raise?: The last disclosed Faze Medicines round closed in December 2020 at Series A.

Round data for Faze Medicines is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Faze Medicines Funding: $81M Raised, Series A (2020)

Faze Medicines funding overview

Faze Medicines at a glance

Frequently asked about Faze Medicines funding

Companies related to Faze Medicines (36)

Browse related funding lists (8)